Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.9 million shares were traded. REAX stock price reached its highest trading level at $5.14 during the session, while it also had its lowest trading level at $4.99.
Ratios:
To gain a deeper understanding of REAX’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.51 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 21.50. For the most recent quarter (mrq), Quick Ratio is recorded 1.22 and its Current Ratio is at 1.22. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, BTIG Research on December 18, 2024, initiated with a Buy rating and assigned the stock a target price of $6.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jan 28 ’25 when JENNA MARIE ROZENBLAT bought 2,635 shares for $4.80 per share.
Gamzu Guy bought 118,903 shares of REAX for $539,820 on Jan 21 ’25. On Jan 02 ’25, another insider, TAMIR POLEG , who serves as the Director of the company, bought 500,000 shares for $4.60 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, REAX now has a Market Capitalization of 997500032 and an Enterprise Value of 955927552. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.91 while its Price-to-Book (P/B) ratio in mrq is 33.18. Its current Enterprise Value per Revenue stands at 0.873 whereas that against EBITDA is -47.808.
Stock Price History:
The Beta on a monthly basis for REAX is 1.51, which has changed by 0.65016496 over the last 52 weeks, in comparison to a change of 0.2000997 over the same period for the S&P500. Over the past 52 weeks, REAX has reached a high of $6.75, while it has fallen to a 52-week low of $2.46. The 50-Day Moving Average of the stock is 2.69%, while the 200-Day Moving Average is calculated to be -1.60%.
Shares Statistics:
It appears that REAX traded 881.03K shares on average per day over the past three months and 818860 shares per day over the past ten days. A total of 197.74M shares are outstanding, with a floating share count of 101.05M. Insiders hold about 49.35% of the company’s shares, while institutions hold 14.29% stake in the company. Shares short for REAX as of 1736899200 were 2983243 with a Short Ratio of 3.40, compared to 1734048000 on 2349234.
Earnings Estimates
The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0.
Revenue Estimates
In the current quarter, 4 analysts expect revenue to total $300.11M. It ranges from a high estimate of $312.7M to a low estimate of $286.66M. As of the current estimate, The Real Brokerage Inc’s year-ago sales were $181.34MFor the next quarter, 4 analysts are estimating revenue of $304.9M. There is a high estimate of $328M for the next quarter, whereas the lowest estimate is $288.5M.
A total of 4 analysts have provided revenue estimates for REAX’s current fiscal year. The highest revenue estimate was $1.23B, while the lowest revenue estimate was $1.2B, resulting in an average revenue estimate of $1.21B. In the same quarter a year ago, actual revenue was $689.16MBased on 4 analysts’ estimates, the company’s revenue will be $1.57B in the next fiscal year. The high estimate is $1.66B and the low estimate is $1.44B.
